Efficacy and distinctive effects of atypical antipsychotics on cognitive symptoms in dual diagnosis – A phase IIIb, randomized, open-labelled study to evaluate the cognitive effects of quetiapine X...
This historical record does not confirm current site availability.
Understand this study
What is this study about?
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
- Listed locations
- Portugal
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
What to know before participating
This is historical registry information. What is the current study status and protocol?
Things to check before joining
- Recruitment status
- Terminated
- Enrollment listed in the registry
- Not clearly listed
- Sponsor
- Unidade de Investigação em Saúde Mental e Psiquiatria do Centro Hospitalar Conde de Ferreira
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- Portugal
- Age range
- Not clearly listed
- Official registry ID
- EUCTR 2007-001520-12
- Official title
Show the full official title
Efficacy and distinctive effects of atypical antipsychotics on cognitive symptoms in dual diagnosis – A phase IIIb, randomized, open-labelled study to evaluate the cognitive effects of quetiapine X...
Recruitment & locations
TerminatedPortugal
Registry details
- Portugal — Prematurely Ended
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is Unidade de Investigação em Saúde Mental e Psiquiatria do Centro Hospitalar Conde de Ferreira.
Is this study still recruiting?
The historical registry lists this study as terminated.
